Evidence map›Paper›PMID 39815293›Full record

ReviewMalaria journal2025

Larviciding for malaria control and elimination in Africa.

Gretchen Newby, Prosper Chaki, Mark Latham, Dulcisária Marrenjo, Eric Ochomo, Derric Nimmo, Edward Thomsen, Allison Tatarsky, Elijah O Juma, Michael Macdonald

Abstract readReview
In one paragraph

Review in Malaria journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Impact of Insecticide-Treated Nets onTropical medicine and infectious disease · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Gretchen NewbyMalaria Elimination Initiative, Institute for Global Health Sciences, University of California, 550 16 St, San Francisco, CA, 94158, USA.
Prosper ChakiPan-African Mosquito Control Association, Kenya Medical Research Institute, Mbagathi Road, PO Box 4445-00100, Nairobi, Kenya.
Mark LathamManatee County Mosquito Control District, 1420 28Th Ave E, Ellenton, FL, 34222, USA.
Dulcisária MarrenjoPrograma Nacional de Controlo da Malária, Ministério da Saúde, Maputo, Mozambique.
Eric OchomoCenter for Global Health Research, Kenya Medical Research Institute, PO Box 1578-40100, Kisumu, Kenya.
Derric NimmoRBM Partnership Vector Control Working Group, Chem du Pommier 40, 1218, Le Grand-Saconnex, Switzerland.
Edward ThomsenMalaria Elimination Initiative, Institute for Global Health Sciences, University of California, 550 16 St, San Francisco, CA, 94158, USA. edward.thomsen@ucsf.edu.
Allison TatarskyMalaria Elimination Initiative, Institute for Global Health Sciences, University of California, 550 16 St, San Francisco, CA, 94158, USA.
Elijah O Juma *Pan-African Mosquito Control Association, Kenya Medical Research Institute, Mbagathi Road, PO Box 4445-00100, Nairobi, Kenya.
Michael Macdonald *RBM Partnership Vector Control Working Group, Chem du Pommier 40, 1218, Le Grand-Saconnex, Switzerland.

Funding

Swiss Agency for Development and Cooperation 81067480UK Aid 30041-105
6 · The paper itself

Abstract

backgroundGlobal progress toward malaria elimination and eradication goals has stagnated in recent years, with many African countries reporting increases in malaria morbidity and mortality. Insecticide-treated nets and indoor residual spraying are effective, but the emergence and increased intensity of insecticide resistance and the challenge of outdoor transmission are undermining their impact. New tools are needed to get back on track towards global targets. This Perspective explores the major challenges hindering wider-scale implementation of larviciding in Africa and identifies potential solutions and opportunities to overcome these barriers. LARVICIDING IN AFRICA: OVERVIEW, CHALLENGES, AND SOLUTIONS: Larviciding is a valuable vector control tool with strong potential for regional scale-up. There is considerable evidence of its effectiveness, and the World Health Organization (WHO) recommends it as a supplemental intervention. However, malaria programmes hoping to implement larviciding face significant barriers, including (1) poor global technical, policy, and funding support; (2) fragmented implementation and experience; (3) high complexity of delivery and impact evaluation; and (4) limited access to the full range of WHO prequalified larvicide products. Strategic barriers related to global policy and donor hesitancy can be overcome through a coordinated demonstration of cost-effectiveness. Technological advancements and strengthened operational capacity have already overcome technical barriers related to larvicide delivery, targeting, coverage, and evaluation. Developing a Community of Practice platform for larviciding has strong potential to consolidate efforts, addressing the challenge of fragmented implementation and experience. Such a platform can serve as a resource center for African malaria programmes, collating and disseminating technical guidance, facilitating the exchange of best practices, and aiding malaria programmes and partners in designing and evaluating larviciding projects.

conclusionThe global shift toward targeted and adaptive interventions enables the incorporation of larviciding into an expanded vector control toolbox. As more African countries implement larvicide programmes, establishing a regional Community of Practice platform for exchanging experiences and best practices is necessary to strengthen the evidence base for cost-effective implementation, advocate for support, and inform policy recommendations, thus supporting Africa's progress toward malaria elimination.

Indexed as

Disease EradicationInsecticidesMalariaMosquito ControlAfricaAnimalsHumansLarvaInsecticidesAfricaGlobal policyLarval source managementLarvicidingMalariaRegional collaboration

Identifiers

PMID39815293
PMCPMC11734449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.